129 related articles for article (PubMed ID: 26428872)
1. Design, synthesis, and biological evaluation of oxindole derivatives as antidepressive agents.
Suthar SK; Bansal S; Alam MM; Jaiswal V; Tiwari A; Chaudhary A; Alex AT; Joseph A
Bioorg Med Chem Lett; 2015 Nov; 25(22):5281-5. PubMed ID: 26428872
[TBL] [Abstract][Full Text] [Related]
2. New Human Monoamine Oxidase A Inhibitors with Potential Anti- Depressant Activity: Design, Synthesis, Biological Screening and Evaluation of Pharmacological Activity.
Evranos-Aksoz B; Ucar G; Tas ST; Aksoz E; Yelekci K; Erikci A; Sara Y; Iskit AB
Comb Chem High Throughput Screen; 2017; 20(6):461-473. PubMed ID: 28474547
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Fisar Z; Hroudová J; Raboch J
Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Evaluation of 2-Amino-6-nitrobenzothiazole-Derived Hydrazones as MAO Inhibitors: Role of the Methylene Spacer Group.
Tripathi RK; Ayyannan SR
ChemMedChem; 2016 Jul; 11(14):1551-67. PubMed ID: 27332045
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 3-Hydroxy-3-phenacyloxindole Analogues of Isatin as Potential Monoamine Oxidase Inhibitors.
Tripathi RK; Krishnamurthy S; Ayyannan SR
ChemMedChem; 2016 Jan; 11(1):119-32. PubMed ID: 26592797
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, conformational analysis and antidepressant activity of moclobemide new analogues.
Ghanbarpour A; Hadizadeh F; Piri F; Rashidi-Ranjbar P
Pharm Acta Helv; 1997 Apr; 72(2):119-22. PubMed ID: 9112832
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase inhibitors: benzylidene-prop-2-ynyl-amines analogues.
Jia Z; Wei S; Zhu Q
Biol Pharm Bull; 2010; 33(4):725-8. PubMed ID: 20410615
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, monoamine oxidase inhibition activity and molecular docking studies of novel 4-hydroxy-N'-[benzylidene or 1-phenylethylidene]-2-H/methyl/benzyl-1,2-benzothiazine-3-carbohydrazide 1,1-dioxides.
Saddique FA; Zaib S; Jalil S; Aslam S; Ahmad M; Sultan S; Naz H; Iqbal M; Iqbal J
Eur J Med Chem; 2018 Jan; 143():1373-1386. PubMed ID: 29126721
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of oxadiazole clubbed piperazine derivatives as potential antidepressant agents.
Sahu B; Bhatia R; Kaur D; Choudhary D; Rawat R; Sharma S; Kumar B
Bioorg Chem; 2023 Jul; 136():106544. PubMed ID: 37116324
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro Evaluation of 2-heteroarylidene-1-tetralone Derivatives as Monoamine Oxidase Inhibitors.
Amakali KT; Legoabe LJ; Petzer A; Petzer JP
Drug Res (Stuttg); 2018 Dec; 68(12):687-695. PubMed ID: 29758567
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibitors of monoamine oxidase. 2. Arylamide SAR.
Harfenist M; Joyner CT; Mize PD; White HL
J Med Chem; 1994 Jun; 37(13):2085-9. PubMed ID: 8027990
[TBL] [Abstract][Full Text] [Related]
12. Exploration of oxadiazole clubbed benzhydrylpiperazine pharmacophoric features as structural feature for antidepressant activity: In vitro, in vivo and in silico analysis.
Kumar Nandi N; Das S; Choudhary D; Saini S; Bhatia R; Chawla P; Kaur R; Kalra S; Rawat R; Eyupoglu V; Kumar B
Bioorg Chem; 2024 Mar; 144():107148. PubMed ID: 38306828
[TBL] [Abstract][Full Text] [Related]
13. Docking, Synthesis, and I
Muthukumaran T; Kumar KA; Francis MS
Curr Comput Aided Drug Des; 2024; 20(5):431-440. PubMed ID: 37231754
[TBL] [Abstract][Full Text] [Related]
14. Methylene Blue Analogues with Marginal Monoamine Oxidase Inhibition Retain Antidepressant-like Activity.
Delport A; Harvey BH; Petzer A; Petzer JP
ACS Chem Neurosci; 2018 Dec; 9(12):2917-2928. PubMed ID: 29976053
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant-like effect of dehydrozingerone from Zingiber officinale by elevating monoamines in brain: in silico and in vivo studies.
Moorkoth S; Prathyusha NS; Manandhar S; Xue Y; Sankhe R; Pai KSR; Kumar N
Pharmacol Rep; 2021 Oct; 73(5):1273-1286. PubMed ID: 34181212
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant-like effects of ferulic acid: involvement of serotonergic and norepinergic systems.
Chen J; Lin D; Zhang C; Li G; Zhang N; Ruan L; Yan Q; Li J; Yu X; Xie X; Pang C; Cao L; Pan J; Xu Y
Metab Brain Dis; 2015 Feb; 30(1):129-36. PubMed ID: 25483788
[TBL] [Abstract][Full Text] [Related]
17. The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant/anticonvulsant agents.
Secci D; Bolasco A; Chimenti P; Carradori S
Curr Med Chem; 2011; 18(33):5114-44. PubMed ID: 22050759
[TBL] [Abstract][Full Text] [Related]
18. Quinazolinone-based benzenesulfonamides with low toxicity and high affinity as monoamine oxidase-A inhibitors: Synthesis, biological evaluation and induced-fit docking studies.
Yamali C; Gul HI; Tugrak Sakarya M; Nurpelin Saglik B; Ece A; Demirel G; Nenni M; Levent S; Cihat Oner A
Bioorg Chem; 2022 Jul; 124():105822. PubMed ID: 35500503
[TBL] [Abstract][Full Text] [Related]
19. Pyrazoline Derivatives as Promising MAO-A Targeting Antidepressants: An Update.
Choudhary D; Kaur R; Singh TG; Kumar B
Curr Top Med Chem; 2024; 24(5):401-415. PubMed ID: 38318823
[TBL] [Abstract][Full Text] [Related]
20. Molecular Docking Studies of Some Novel Antidepressant 5-Substituted Phenyl-3-(Thiophen-2-yl)-4, 5-Dihydro-1h-Pyrazole-1-Carboxamides Against Monoamine Oxidase Isoforms.
Mathew B; Suresh J; Anbazhagan S; Dev S
Cent Nerv Syst Agents Med Chem; 2016; 16(2):75-80. PubMed ID: 25687583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
